#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neovascular age-related macular degeneration Deafness bilateral Pelizaeus-Merzbacher disease Fragile X syndrome Immunoglobulin G4 related disease Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Cervix carcinoma recurrent Brain stem glioma Astrocytoma malignant Synovial sarcoma metastatic Neuropathy peripheral Anaplastic thyroid cancer Microscopic polyangiitis Rheumatoid arthritis Isodicentric chromosome 15 syndrome More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Treatment Short-bowel syndrome – Diagnostics Marfan’s syndrome Angiosarcoma metastatic – Treatment Myelodysplastic syndrome – Treatment Krabbe’s disease Undifferentiated sarcoma – Life with Disease Skin angiosarcoma – Trials in Disease Sarcoma – Basic Information Haemophagocytic lymphohistiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Munc-Cd34 Voxelotor Dostarlimab Taldefgrobep Alfa Ucart20X22 Palivizumab Amitriptyline Hydrochloride Abacavir Levodropropizine Metoclopramide Hydrochloride Human Coagulation Factor Ix Lifileucel Neflamapimod Mogamulizumab Eik1003 Sacituzumab Tirumotecan Bi 765845 Azilsartan Medoxomil Mosliciguat DNL593 More therapies…

    Learn about Your Condition

    Turner's syndrome Metachromatic leukodystrophy Polycystic ovarian syndrome Neonatal hyperglycaemia Cancer fatigue Postoperative delirium T-cell type acute leukaemia Pyoderma Macular telangiectasia Ewing's sarcoma metastatic Gaucher's disease type III Vulvovaginal candidiasis Lung cancer metastatic Glomerulonephritis membranous Systemic candida More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on the Effects of Tirzepatide on Reducing Alcohol Intake in Patients with Schizophrenia and Alcohol Use Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    • Schizophrenia
    Investigated Drugs:
    • Sodium Chloride
    • Tirzepatide
    Denmark

  • Study on Sodium Benzoate and Clozapine for Adults with Refractory Schizophrenia Symptoms

    Recruiting

    4 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • SODIUM BENZOATE
    Poland

  • Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • SELTOREXANT
    Bulgaria Czechia Italy Poland Portugal Romania +3

  • Study on the Safety and Effectiveness of Dexamfetamine Sulfate for Adults with ADHD and Moderate to Severe Depression

    Recruiting

    2 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Major depression
    Investigated Drugs:
    • Dexamfetamine Sulfate
    Germany

  • Study on the Effects of Escitalopram, Naltrexone, and Their Combination on Reducing Symptoms of Compulsive Sexual Behavior Disorder in Affected Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Compulsive sexual behaviour
    Investigated Drugs:
    • Escitalopram Oxalate
    • Naltrexone Hydrochloride
    Poland

  • Study on the Effects of Estradiol, Progesterone, and Online Sleep Therapy for Insomnia and Menopausal Symptoms in Perimenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Insomnia
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    The Netherlands
Previous Page
1 … 8 9 10 11 12 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!